Arthur He
Stock Analyst at HC Wainwright & Co.
(0)
# 4799
Out of 5,270 analysts
74
Total ratings
25.53%
Success rate
-23.31%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Prime Medicine | Reiterates: Buy | 10 10 | 2.28 | 338.6% | 6 | Mar 3, 2025 | |
LAVA Therapeutics | Downgrades: Neutral | 2 2 | 1.28 | 17.19% | 9 | Feb 27, 2025 | |
Nektar Therapeutics | Reiterates: Buy | 7 7 | 0.83 | 683.13% | 2 | Feb 25, 2025 | |
Adagene | Maintains: Strong Buy | 5 8 | 2.04 | 292.16% | 9 | Jan 27, 2025 | |
Solid Biosciences | Reiterates: Buy | 16 16 | 5.29 | 202.46% | 8 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 9 | n/a | n/a | 17 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 4 4 | 0.53 | 560.38% | 5 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 39 | n/a | n/a | 4 | May 28, 2024 |